Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma.

Zhou YM, Cao L, Li B, Zhang XZ, Yin ZF.

Hepatobiliary Pancreat Dis Int. 2012 Oct;11(5):532-5.

PMID:
23060400
[PubMed - indexed for MEDLINE]
Free Article
2.

A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver.

Liu W, Chen JR, Hsu CH, Li YH, Chen YM, Lin CY, Huang SJ, Chang ZK, Chen YC, Lin CH, Gong HY, Lin CC, Kawakami K, Wu JL.

Hepatology. 2012 Dec;56(6):2268-76. doi: 10.1002/hep.25914.

PMID:
22729936
[PubMed - indexed for MEDLINE]
3.

Hepatitis B virus and intrahepatic cholangiocarcinoma.

Gatselis NK, Tepetes K, Loukopoulos A, Vasiou K, Zafiriou A, Gioti C, Dalekos GN.

Cancer Invest. 2007 Feb;25(1):55-8.

PMID:
17364558
[PubMed - indexed for MEDLINE]
4.

Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.

Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 Jul;31(7):1059-67.

PMID:
17592273
[PubMed - indexed for MEDLINE]
5.

[Pathogenesis of hilar cholangiocarcinoma and infection of hepatitis virus].

Liu X, Zou S, Qiu F.

Zhonghua Wai Ke Za Zhi. 2002 Jun;40(6):420-2. Chinese.

PMID:
12139797
[PubMed - indexed for MEDLINE]
6.

Intrahepatic cholangiocarcinoma: new insights in pathology.

Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.

Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22. Review.

PMID:
21344350
[PubMed - indexed for MEDLINE]
7.

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.

Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM.

Am J Gastroenterol. 2007 May;102(5):1016-21. Epub 2007 Feb 23.

PMID:
17324130
[PubMed - indexed for MEDLINE]
8.

Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.

Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY.

Hepatology. 2012 Jan;55(1):108-20. doi: 10.1002/hep.24675. Epub 2011 Dec 6.

PMID:
21932402
[PubMed - indexed for MEDLINE]
9.

Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.

Shimonishi T, Isse K, Shibata F, Aburatani I, Tsuneyama K, Sabit H, Harada K, Miyazaki K, Nakanuma Y.

Hepatology. 2000 Oct;32(4 Pt 1):761-9.

PMID:
11003620
[PubMed - indexed for MEDLINE]
10.

Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.

Zhou H, Wang H, Zhou D, Wang H, Wang Q, Zou S, Tu Q, Wu M, Hu H.

Eur J Cancer. 2010 Apr;46(6):1056-61. doi: 10.1016/j.ejca.2010.02.005. Epub 2010 Mar 4.

PMID:
20202823
[PubMed - indexed for MEDLINE]
11.

Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus.

Peng NF, Li LQ, Qin X, Guo Y, Peng T, Xiao KY, Chen XG, Yang YF, Su ZX, Chen B, Su M, Qi LN.

Ann Surg Oncol. 2011 May;18(5):1258-66. doi: 10.1245/s10434-010-1458-5. Epub 2011 Jan 5.

PMID:
21207172
[PubMed - indexed for MEDLINE]
13.

Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus.

Liu XF, Zou SQ, Qiu FZ.

Hepatobiliary Pancreat Dis Int. 2003 May;2(2):285-9.

PMID:
14599986
[PubMed - indexed for MEDLINE]
Free Article
14.

Cholangiocarcinoma with a background of hepatitis B virus-associated cirrhosis.

Takegoshi K, Su Q, Omata M, Taira S, Okada E, Bannasch P.

Intern Med. 2001 May;40(5):382-5.

PMID:
11393406
[PubMed - indexed for MEDLINE]
Free Article
15.

Hepatitis B virus X protein inhibits nucleotide excision repair.

Jia L, Wang XW, Harris CC.

Int J Cancer. 1999 Mar 15;80(6):875-9.

PMID:
10074921
[PubMed - indexed for MEDLINE]
16.

Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.

Zhu P, Tan D, Peng Z, Liu F, Song L.

Acta Biochim Biophys Sin (Shanghai). 2007 Apr;39(4):265-72.

PMID:
17417681
[PubMed - indexed for MEDLINE]
Free Article
17.

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H.

J Med Virol. 2000 Oct;62(2):151-8.

PMID:
11002243
[PubMed - indexed for MEDLINE]
18.

[Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].

Wang X, Zhang J, Chen J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Feb;22(1):57-60. Chinese.

PMID:
12903495
[PubMed - indexed for MEDLINE]
19.

Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.

Furubo S, Harada K, Shimonishi T, Katayanagi K, Tsui W, Nakanuma Y.

Histopathology. 1999 Sep;35(3):230-40.

PMID:
10469215
[PubMed - indexed for MEDLINE]
20.

Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.

Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T.

Int J Oncol. 2009 Mar;34(3):649-56.

PMID:
19212669
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk